269 related articles for article (PubMed ID: 24384850)
1. Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis.
Miettinen M
Mod Pathol; 2014 Jan; 27 Suppl 1(Suppl 1):S17-29. PubMed ID: 24384850
[TBL] [Abstract][Full Text] [Related]
2. Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes.
Billings SD; Folpe AL; Weiss SW
Am J Surg Pathol; 2001 Sep; 25(9):1134-42. PubMed ID: 11688572
[TBL] [Abstract][Full Text] [Related]
3. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS.
McClain KL; Leach CT; Jenson HB; Joshi VV; Pollock BH; Parmley RT; DiCarlo FJ; Chadwick EG; Murphy SB
N Engl J Med; 1995 Jan; 332(1):12-8. PubMed ID: 7990860
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
5. Inguinal smooth muscle tumors in women-a dichotomous group consisting of Müllerian-type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases.
Patil DT; Laskin WB; Fetsch JF; Miettinen M
Am J Surg Pathol; 2011 Mar; 35(3):315-24. PubMed ID: 21297441
[TBL] [Abstract][Full Text] [Related]
6. Tumors with smooth muscle differentiation.
Spencer JM; Amonette RA
Dermatol Surg; 1996 Sep; 22(9):761-8. PubMed ID: 8874523
[TBL] [Abstract][Full Text] [Related]
7. Smooth muscle tumors of soft tissue.
Weiss SW
Adv Anat Pathol; 2002 Nov; 9(6):351-9. PubMed ID: 12409644
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of biological potential of smooth muscle tumours.
Miettinen M; Fetsch JF
Histopathology; 2006 Jan; 48(1):97-105. PubMed ID: 16359541
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.
Oda Y; Miyajima K; Kawaguchi K; Tamiya S; Oshiro Y; Hachitanda Y; Oya M; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2001 Aug; 25(8):1030-8. PubMed ID: 11474287
[TBL] [Abstract][Full Text] [Related]
10. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
[TBL] [Abstract][Full Text] [Related]
11. A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors.
Lee CH; Turbin DA; Sung YC; Espinosa I; Montgomery K; van de Rijn M; Gilks CB
Mod Pathol; 2009 Dec; 22(12):1519-31. PubMed ID: 19734847
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 Expression and Tumor-infiltrating Lymphocytes in Uterine Smooth Muscle Tumors: Implications for Immunotherapy.
Shanes ED; Friedman LA; Mills AM
Am J Surg Pathol; 2019 Jun; 43(6):792-801. PubMed ID: 31009388
[TBL] [Abstract][Full Text] [Related]
13. MED12 alterations in both human benign and malignant uterine soft tissue tumors.
Pérot G; Croce S; Ribeiro A; Lagarde P; Velasco V; Neuville A; Coindre JM; Stoeckle E; Floquet A; MacGrogan G; Chibon F
PLoS One; 2012; 7(6):e40015. PubMed ID: 22768200
[TBL] [Abstract][Full Text] [Related]
14. Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors.
Robin YM; Penel N; Pérot G; Neuville A; Vélasco V; Ranchère-Vince D; Terrier P; Coindre JM
Mod Pathol; 2013 Apr; 26(4):502-10. PubMed ID: 23174934
[TBL] [Abstract][Full Text] [Related]
15. Sinonasal smooth muscle cell tumors: a clinicopathologic and immunohistochemical analysis of 12 cases with emphasis on the low-grade end of the spectrum.
Huang HY; Antonescu CR
Arch Pathol Lab Med; 2003 Mar; 127(3):297-304. PubMed ID: 12653572
[TBL] [Abstract][Full Text] [Related]
16. HMGIC alterations in smooth muscle tumors of soft tissues and other sites.
Hisaoka M; Sheng WQ; Tanaka A; Hashimoto H
Cancer Genet Cytogenet; 2002 Oct; 138(1):50-5. PubMed ID: 12419585
[TBL] [Abstract][Full Text] [Related]
17. Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma.
Cornejo K; Shi M; Jiang Z
Hum Pathol; 2012 Oct; 43(10):1567-72. PubMed ID: 22497850
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas.
Paal E; Miettinen M
Am J Surg Pathol; 2001 Nov; 25(11):1355-63. PubMed ID: 11684951
[TBL] [Abstract][Full Text] [Related]
19. Intermediate and fine filaments of vascular leiomyomas (angiomyoma), leiomyoma and leiomyosarcomas of large veins.
Lundgren L; Seidal T; Kindblom LG; Angervall L
APMIS; 1989 Jul; 97(7):637-45. PubMed ID: 2751898
[TBL] [Abstract][Full Text] [Related]
20. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
